Insider plans sale of 6,000 AMRK shares (NYSE: AMRK)

Rhea-AI Filing Summary

AMRK reports an insider sale notice to sell 6,000 shares. The filing shows the sale is linked to a stock option exercise and scheduled for 02/27/2026 via a broker check. The excerpt also records a prior sale of 750 shares on 12/11/2025 for $23,459.88.

Insights

Insider Transactions Analyst

Small, routine insider sale tied to option exercise; timing and method are specified.

The filing lists a proposed sale of 6,000 shares via a stock option exercise to occur on 02/27/2026, executed through a broker check. This format is consistent with routine disclosures of option-related dispositions.

Prior activity includes a reported sale of 750 shares on 12/11/2025 for $23,459.88. The cash‑flow recipient and post-sale ownership levels are not shown in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab & Co 3000 Schwab Way Westlake TX 76262	6000	337140.00	25296992	02/27/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/27/2026	Stock Option Exercise	Issuer			6000	02/27/2026	Broker Check

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Carol Meltzer 1550 SCENIC AVE. SUITE 150 COSTA MESA CA 92626	Common Stock	12/11/2025	750	23459.88

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AMRK's Form 144 disclose about the planned sale?

The Form 144 discloses a planned sale of 6,000 common shares associated with a stock option exercise and scheduled for 02/27/2026, to be handled via a broker check.

Who previously sold AMRK shares and for how much?

A prior sale listed in the excerpt shows 750 shares sold on 12/11/2025 for $23,459.88, attributed to the named individual in the filing.

Does the filing state how the sale will be executed for AMRK?

Yes. The planned 6,000-share disposition is described as a stock option exercise with execution noted as a broker check, scheduled on 02/27/2026.

Is the Form 144 sale subject to any special restrictions in the excerpt?

The excerpt specifies the sale method and date but does not state any additional restrictions or beneficial ownership limits; no gating qualifiers appear in the provided text.

What information about proceeds or beneficiary is provided?

The excerpt shows proceeds for a prior sale ($23,459.88) but does not state who receives proceeds for the planned 6,000-share transaction or post‑sale ownership in the provided text.